Business / Corporate | FOCUS Feb 3, 2019
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
by Julie Steenhuysen
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year. Takeda Pharmaceutical Co. plans to seek approval for the experimental vaccine first in countries where the virus is endemic, ...
